Earnings History Data for MiMedx Group, Inc (MDXG) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

MiMedx Group, Inc

MiMedx is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. `Innovations in Regenerative Biomaterials` is the framework behind their mission to give physicians products and tissues to help the body heal itself. Their biomaterial platform technologies include AmnioFix and EpiFix, their tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through their donor program, a mother delivering via full-term Caesarean section birth can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. They process the human amniotic membrane utilizing their proprietary PURION Process, to produce a safe and effective implant.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
02-08-2022 AH 4:30 PM ET
(Aug 2)
MDXG MiMedx Group, Inc 384.27 -0.11 -0.06 -0.03 MiMedx Group GAAP EPS of -$0.11 misses by $0.04, revenue of $66.88M beats by $1.81M
[8/2/2022 5:01 PM]
3.70 0.26 
(7.56%)
3.69 0.25 
(7.27%)
3.04 - 15.99 696,089 320,000 501
03-05-2022 AH 4:05 PM ET
(May 3)
MDXG MiMedx Group 460.00 -0.11 -0.10 0.00 MiMedx Group GAAP EPS of -$0.11 misses by $0.01, revenue of $58.89M beats by $4.79M
[5/3/2022 4:39 PM]
4.38 0.30 
(7.21%)
4.05 -0.04 
(-0.98%)
3.75 - 15.99 375,708 530,000 3,011
28-02-2022 AH 4:50 PM ET
(Feb 28)
MDXG MiMedx Group, Inc 539.41 0.01 -0.03 -0.17 MiMedx Group GAAP EPS of $0.01 beats by $0.04, revenue of $67.29M beats by $3.6M
[2/28/2022 4:24 PM]
5.02 -0.03 
(-0.59%)
5.26 0.21 
(4.16%)
4.12 - 15.99 327,595 540,000 28,048
02-11-2021 AH 5:20 PM ET
(Nov 2)
MDXG MiMedx Group, Inc 764.62 -0.04 -0.08 -0.48 MiMedx Group EPS beats by $0.05, beats on revenue
[11/2/2021 4:50 PM]
8.11 1.08 
(15.36%)
7.20 0.17 
(2.42%)
5.30 - 15.99 917,747 610,000 3,318
03-08-2021 AH 5:00 PM ET
(Aug 3)
MDXG MiMedx Group, Inc 1,370 -0.03 -0.07 -0.08 MiMedx Group EPS beats by $0.04, beats on revenue
[8/3/2021 5:27 PM]
11.89 -0.66 
(-5.26%)
11.89 0.0 
(0.00%)
5.32 - 13.02 535,412 460,000 8,078
28-04-2021 AH 5:30 PM ET
(Apr 28)
MDXG MiMedx Group, Inc 1,180 -0.09 -0.19 -0.04 MiMedx Group EPS beats by $0.10, misses on revenue
[4/28/2021 5:04 PM]
10.19 -0.52 
(-4.90%)
10.20 -0.51 
(-4.76%)
3.30 - 12.87 1,157,463 510,000 12,558
08-03-2021 AH 4:05 PM ET
(Mar 8)
MDXG MiMedx Group, Inc 1,120 -0.17 -0.05 -0.34 MiMedx Group EPS misses by $0.12, beats on revenue
[3/8/2021 5:41 PM]
8.96 -0.96 
(-9.68%)
9.70 -0.22 
(-2.22%)
2.95 - 11.44 1,045,064 572,069 3,520
04-11-2020 AH After the close
(Nov 4)
MDXG MiMedx Group, Inc 690.64 -0.48 0.00 0.00 MiMedx Group reports Q3 results
[11/4/2020 4:20 PM]
6.72 -0.51 
(-7.05%)
7.59 0.36 
(4.98%)
2.95 - 7.95 447,014 318,907 266